What's new
New posts
New media
New media comments
New profile posts
New review items
Latest activity
Forums
New posts
Search forums
Gallery
New media
New comments
Search media
Reviews
New items
Latest content
Latest reviews
Latest questions
Brands
Search reviews
Opus
Birds & Bird Song
Locations
Resources
Contribute
Recent changes
Blogs
Members
Current visitors
New profile posts
Search profile posts
ZEISS
ZEISS Nature Observation
The Most Important Optical Parameters
Innovative Technologies
Conservation Projects
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
BirdForum is the net's largest birding community dedicated to wild birds and birding, and is
absolutely FREE
!
Register for an account
to take part in lively discussions in the forum, post your pictures in the gallery and more.
Forums
Birding
Conservation
Unsubstantiated claims from Basra Reed Warbler study
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Klaas van Dijk" data-source="post: 3596232" data-attributes="member: 115771"><p>I noted a research integrity issue related to the efforts to retract both fraudulent articles on the Basra Reed Warbler with one of the members of the editorial board of the journal 'Research Integrity and Peer Review' <a href="https://researchintegrityjournal.biomedcentral.com/" target="_blank">https://researchintegrityjournal.biomedcentral.com/</a> I have therefore contacted on 12 July 2017 the rather recently appointed Editor-in-Chief Dr. Joerg Meerpohl about this issue. Dr. Meerpohl is one of the Editors-in-Chief of this journal and co-director of Cochrane Germany, <a href="http://www.cochrane.de/welcome" target="_blank">http://www.cochrane.de/welcome</a> and <a href="http://www.open-project.eu/project-partners" target="_blank">http://www.open-project.eu/project-partners</a></p><p></p><p>I have in the meanwhile extensive experiences that communicating about the main findings of <a href="https://www.academia.edu/33827046" target="_blank">https://www.academia.edu/33827046</a> with editors and others in the publication industry, and in the widest possible sense, is extremely difficult. In other words, it is almost impossible to communicate with editors and others in the publication industry, and in the widest possible sense, about the main findings of <a href="https://www.academia.edu/33827046" target="_blank">https://www.academia.edu/33827046</a> (so often 'no response' and 'no response' and 'no response', etc, and/or sometimes responses without substance and with comments like 'this case is closed', etc.). </p><p></p><p>It is on the other hand very fortunate that editors and others in the publication industry, and in the widest possible sense, are very used to communicate with each other and with 3th parties through the concept of 'tacit approval within a fixed period of time' (for example one working day, or five working days, etc). In other words, communicating with each other through the concept of 'tacit approval within a fixed period of time' is common practice within the field of publication ethics and for people who are active in the publication industry, and in the widest possible sense.</p><p></p><p>I have therefore sent Dr. Meerpohl the next day, on 13 July 2017, a follow-up with backgrounds and with a proposal to communicate with me about the main findings of the report '<em>Final investigation on serious allegations of fabricated and/or falsified data in Al-Sheikhly et al. (2013, 2015) - 1 July 2016</em>' at <a href="https://www.academia.edu/33827046" target="_blank">https://www.academia.edu/33827046</a> within the framework of tacit approval within a fixed period of time. I received the same day a response from Dr. Meerpohl in which he told me to look into this issue and to come back with me in due time. Dr. Meerpohl did not mention in this response that he had objections to work within the framework of tacit approval within a fixed period of time when communicating with me about the main findings of <a href="https://www.academia.edu/33827046" target="_blank">https://www.academia.edu/33827046</a> Dr. Meerpohl listed in this response also no objections against the statement in my first email of that day to him in which it is stated: "Dr. Meerpohl supports the main findings of the 'Final Investigation' at <a href="https://www.academia.edu/33827046" target="_blank">https://www.academia.edu/33827046</a> that Al-Sheikhly <em>et al</em>. (2013, 2015) contains fabricated and/or falsified data and that therefore Al-Sheikhly <em>et al</em>. (2013, 2015) must be retracted, and as soon as possible."</p><p></p><p>I received on 27 July 2017 a follow-up from Dr. Meerpohl. Dr. Meerpohl told me in this follow-up that he had consulted with other Editors-in-Chief of the journal about the research integrity issue with one of the members of the editorial board. He told me that they had decided to consider this matter as closed. Dr. Meerpohl once again did not object in this email of 27 July 2017 that I am allowed to communicate with him about the main findings of the 'Final Investigation' at <a href="https://www.academia.edu/33827046" target="_blank">https://www.academia.edu/33827046</a> within the framework of tacit approval within a fixed period of time. </p><p></p><p>It can therefore be concluded that it is correct to state that Dr. Joerg Meerpohl, the co-director of Cochrane Germany and one of the Editors-in-Chief of the journal 'Research Integrity and Peer Review' "supports the main findings of the Final Investigation at <a href="https://www.academia.edu/33827046" target="_blank">https://www.academia.edu/33827046</a> that Al-Sheikhly <em>et al</em>. (2013, 2015) contains fabricated and/or falsified data and that therefore Al-Sheikhly <em>et al</em>. (2013, 2015) must be retracted, and as soon as possible."</p><p></p><p>It is towards my opinion a major set-back for Editor-in-Chief and German citizen Dr. Max Kasparek that he now must accept that also the co-director of Cochrane Germany, as well one of the Editors-in-Chief of the journal 'Research Integrity and Peer Review', supports the main findings of <a href="https://www.academia.edu/33827046" target="_blank">https://www.academia.edu/33827046</a> that Al-Sheikhly <em>et al</em>. (2013, 2015) contains fabricated and/or falsified data and that therefore Al-Sheikhly <em>et al</em>. (2013, 2015) must be retracted, and as soon as possible.</p><p></p><p>Dr. Kasparek and/or anyone else has until now not responded / commented on <a href="http://www.birdforum.net/showpost.php?p=3594282&postcount=26" target="_blank">http://www.birdforum.net/showpost.php?p=3594282&postcount=26</a></p></blockquote><p></p>
[QUOTE="Klaas van Dijk, post: 3596232, member: 115771"] I noted a research integrity issue related to the efforts to retract both fraudulent articles on the Basra Reed Warbler with one of the members of the editorial board of the journal 'Research Integrity and Peer Review' [url]https://researchintegrityjournal.biomedcentral.com/[/url] I have therefore contacted on 12 July 2017 the rather recently appointed Editor-in-Chief Dr. Joerg Meerpohl about this issue. Dr. Meerpohl is one of the Editors-in-Chief of this journal and co-director of Cochrane Germany, [url]http://www.cochrane.de/welcome[/url] and [url]http://www.open-project.eu/project-partners[/url] I have in the meanwhile extensive experiences that communicating about the main findings of [url]https://www.academia.edu/33827046[/url] with editors and others in the publication industry, and in the widest possible sense, is extremely difficult. In other words, it is almost impossible to communicate with editors and others in the publication industry, and in the widest possible sense, about the main findings of [url]https://www.academia.edu/33827046[/url] (so often 'no response' and 'no response' and 'no response', etc, and/or sometimes responses without substance and with comments like 'this case is closed', etc.). It is on the other hand very fortunate that editors and others in the publication industry, and in the widest possible sense, are very used to communicate with each other and with 3th parties through the concept of 'tacit approval within a fixed period of time' (for example one working day, or five working days, etc). In other words, communicating with each other through the concept of 'tacit approval within a fixed period of time' is common practice within the field of publication ethics and for people who are active in the publication industry, and in the widest possible sense. I have therefore sent Dr. Meerpohl the next day, on 13 July 2017, a follow-up with backgrounds and with a proposal to communicate with me about the main findings of the report '[I]Final investigation on serious allegations of fabricated and/or falsified data in Al-Sheikhly et al. (2013, 2015) - 1 July 2016[/I]' at [url]https://www.academia.edu/33827046[/url] within the framework of tacit approval within a fixed period of time. I received the same day a response from Dr. Meerpohl in which he told me to look into this issue and to come back with me in due time. Dr. Meerpohl did not mention in this response that he had objections to work within the framework of tacit approval within a fixed period of time when communicating with me about the main findings of [url]https://www.academia.edu/33827046[/url] Dr. Meerpohl listed in this response also no objections against the statement in my first email of that day to him in which it is stated: "Dr. Meerpohl supports the main findings of the 'Final Investigation' at [url]https://www.academia.edu/33827046[/url] that Al-Sheikhly [I]et al[/I]. (2013, 2015) contains fabricated and/or falsified data and that therefore Al-Sheikhly [I]et al[/I]. (2013, 2015) must be retracted, and as soon as possible." I received on 27 July 2017 a follow-up from Dr. Meerpohl. Dr. Meerpohl told me in this follow-up that he had consulted with other Editors-in-Chief of the journal about the research integrity issue with one of the members of the editorial board. He told me that they had decided to consider this matter as closed. Dr. Meerpohl once again did not object in this email of 27 July 2017 that I am allowed to communicate with him about the main findings of the 'Final Investigation' at [url]https://www.academia.edu/33827046[/url] within the framework of tacit approval within a fixed period of time. It can therefore be concluded that it is correct to state that Dr. Joerg Meerpohl, the co-director of Cochrane Germany and one of the Editors-in-Chief of the journal 'Research Integrity and Peer Review' "supports the main findings of the Final Investigation at [url]https://www.academia.edu/33827046[/url] that Al-Sheikhly [I]et al[/I]. (2013, 2015) contains fabricated and/or falsified data and that therefore Al-Sheikhly [I]et al[/I]. (2013, 2015) must be retracted, and as soon as possible." It is towards my opinion a major set-back for Editor-in-Chief and German citizen Dr. Max Kasparek that he now must accept that also the co-director of Cochrane Germany, as well one of the Editors-in-Chief of the journal 'Research Integrity and Peer Review', supports the main findings of [url]https://www.academia.edu/33827046[/url] that Al-Sheikhly [I]et al[/I]. (2013, 2015) contains fabricated and/or falsified data and that therefore Al-Sheikhly [I]et al[/I]. (2013, 2015) must be retracted, and as soon as possible. Dr. Kasparek and/or anyone else has until now not responded / commented on [url]http://www.birdforum.net/showpost.php?p=3594282&postcount=26[/url] [/QUOTE]
Insert quotes...
Verification
Post reply
Forums
Birding
Conservation
Unsubstantiated claims from Basra Reed Warbler study
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more...
Top